Published in Medical Letter on the CDC and FDA, February 12th, 2006
The company sees this as a positive development since, as an FDA-approved OTC drug, PreHistin would not require a doctor's prescription, thus making consumer purchases easier, faster, and more convenient. Based on an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.